mardi 13 octobre 2020

Eli Lilly’s Antibody Trial Is Paused Over Potential Safety Concern

The drugmaker’s experimental antibody treatment is similar to the one President Trump received from Regeneron.

from NYT > Health https://ift.tt/2GYTcCd
via health&fitness

Aucun commentaire:

Enregistrer un commentaire